Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?

Detalles Bibliográficos
Autores principales: Macaluso, Fabio Salvatore, Orlando, Ambrogio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214317/
https://www.ncbi.nlm.nih.gov/pubmed/32407807
http://dx.doi.org/10.1053/j.gastro.2020.05.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214317/
https://www.ncbi.nlm.nih.gov/pubmed/32407807
http://dx.doi.org/10.1053/j.gastro.2020.05.026

Ejemplares similares